Ionis Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Great. Good morning, everyone. Thank you so much for joining us. It's my pleasure to introduce Ionis. And with us, we have Brett Monia, CEO. Brett, thank you for being here.
Pleasure, Salveen, and great to be here.
Questions & Answers
So to start here, you've laid out a transition to a more balanced portfolio in terms of your wholly owned and partnered programs and now have independent launches as well as several wholly owned pipeline programs. Could you just start with discussing how you've executed on the transition and your key priorities as you look to the outlook into the end of this decade?
Yeah, happy to. So we are going through a transition evolution. Really, it's the product of a vision that I laid out when I moved into this role as CEO in January of 2020. Really focused on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
